Print this documentEmail this document
Conquering disease through knowledge

Studies

The physicians at Genova Clinical Research have participated in and may have current research studies involving:

Diabetic Neuropathy

Over 20% of the diabetic population suffers from sensory loss, numbness or pain due to diabetic nerve damage (neuropathy).  Genova Clinical Research, Inc. is conducting a clinical drug study investigating the safety and efficacy of two dosages of an investigational drug vs. placebo (an inactive substance) in subjects with DSPN.  This study lasts approximately 25 months and has 13 visits.  Qualified participants may receive study related physicals, study drug and lab work will be provided.  Reimbursement is available for qualified participants.

Subjects must:

If you are interested in finding out more about this study please call us at (520) 219-6394. 

Register Now

Diabetic Neuropathy

Genova Clinical Research, Inc. is conducting a research study of an investigational drug versus oxycodone for the treatment of chronic, painful diabetic peripheral neuropathy. This study is open label meaning both the physician and the subject know the study drug and dose of the study drug assigned.

This study lasts approximately 54 weeks and includes 20 visits. Qualified participants will receive study medications, study related physicals, and lab work at no charge.  Compensation may be available to qualified participants for each completed visit for time and travel expenses. 

If you are interested in this study, you should:

If you are interested in finding out more about this study, please call us as 520-219-6394.  One of our staff will be happy to give you further information regarding this study and will schedule an appointment to allow you to discuss the study in more detail with one of our physicians.

Register Now